| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.91B | — | +4.5% |
| Cost of Revenue | $1.61B | — | +2.2% |
| Gross Profit | $2.30B | — | +6.2% |
| R&D Expense | $84.0M | — | -15.2% |
| SG&A Expense | $1.45B | — | -5.5% |
| Operating Income | $767.0M | — | +37.5% |
| Interest Expense | $106.0M | — | -0.9% |
| Pre-tax Income | $672.0M | — | +46.7% |
| Income Tax | $198.0M | — | +45.6% |
| Net Income | $474.0M | — | +47.2% |
| EPS (Basic) | $0.25 | — | +47.1% |
| EPS (Diluted) | $0.25 | — | +47.1% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.07B | +1.2% | +1.7% |
| Accounts Receivable | $2.50B | +5.0% | +8.2% |
| Inventory | $1.67B | +0.5% | -0.4% |
| Current Assets | $5.79B | +1.7% | +1.5% |
| Total Assets | $26.85B | -0.8% | +2.3% |
| Current Liabilities | $5.90B | -0.8% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $489.0M | — | +14.3% |
| Capital Expenditures | $139.0M | — | -22.3% |
| Investing Cash Flow | -$167.0M | — | +0.0% |
| Financing Cash Flow | -$295.0M | — | +4.8% |
| Free Cash Flow | $350.0M | — | +40.6% |
| -11.6% |
| Total Liabilities | $16.25B | -0.4% | +0.3% |
| Stockholders' Equity | $10.61B | -1.5% | +5.5% |